| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 08/28/2008 | US20080207490 Glucose Uptake Modulator and Method for Treating Diabetes or Diabetic Complications |
| 08/28/2008 | US20080207489 Use of CCN5 for treatment of smooth muscle proliferation disorders |
| 08/28/2008 | US20080207488 Removal of conformational altered protein; side effect reduction |
| 08/28/2008 | US20080207487 Manufacturing process for the production of polypeptides expressed in insect cell-lines |
| 08/28/2008 | US20080207486 Compositions and methods for the therapy and diagnosis of breast cancer |
| 08/28/2008 | US20080207485 Major histocompatibility complex with peptide binding grooves; controlling oligomerization |
| 08/28/2008 | US20080207484 Polypeptides; hybrid nucleic acids; anticancer agents; central nervous system disorders |
| 08/28/2008 | US20080207483 Methods and compositions for diagnosis and therapy of cancer based on hyper-mutated tumor genes |
| 08/28/2008 | US20080206750 Novel fetal genes |
| 08/28/2008 | US20080206738 Reduce concentration of nitric oxide ; antiinflamamtory agents, stroke, antiproliferative agents; gastrointestinal disorders; inflammatory bowel disorders; antiarthritic agents; Parkinson's disease; Alzheimer's disease;amyotroic lateral sclerosis; anticancer agents |
| 08/28/2008 | US20080206365 2-hydroxy-2-substituted-3,10a-ethanophenanthrolines; inhibitors or activators for cytokine production; viricide, antiarthritic, anticarcinogenic, anticholesterol agents; myocardial infarction, osteoporosis, diabetes complications, sepsis, myeloma, transplant rejection, cirrhosis, AIDS, multiple sclerosis |
| 08/28/2008 | US20080206342 Compositions and Methods For Increasing the Bioavailability of Pulmonarily Administered Insulin |
| 08/28/2008 | US20080206317 Ternary Non-Lamellar Lipid Compositions |
| 08/28/2008 | US20080206309 Antagonists of prostaglandin receptors ep2 and/or ep4 for the treatment of dysmenorrhea and menorrhagia |
| 08/28/2008 | US20080206308 comprising a biodegradable unsaturated polymer selecting from polypropylene fumarate and polycaprolactone fumarate and a curing agent to form a porous scaffold in an mold or in a body cavity; for tissue regeneration; drug delivery devices; biodegradable, biocompatible scaffolds for tissue engineering |
| 08/28/2008 | US20080206302 cohesive, structure-forming matrix including gel, with open porosity and serum for regenerating cartilage, bone tissue; drug delivery device and method |
| 08/28/2008 | US20080206300 Shaped Article |
| 08/28/2008 | US20080206298 Enhanced biological autologous tissue adhesive composition and methods of preparation and use |
| 08/28/2008 | US20080206297 orthopedic implants; composite material for use as a scaffolds; thermoplastic polymer forming a porous matrix with embedded in anisometric calcium phosphate particles; reinforcement, bioactivity, bioresorption; selectively varying the porosity; bonding between the implant and the tissure |
| 08/28/2008 | US20080206293 Absorbent substrate with a non-leaching antimicrobial activity and a controlled-release bioactive agent. |
| 08/28/2008 | US20080206287 synergistic anticarcinogenic treatment including vaccine which has a tumor necrosis factor death domains |
| 08/28/2008 | US20080206284 E. coli heat-labile enterotoxin that binds to GM1 ganglioside receptors; allergic rhinitis |
| 08/28/2008 | US20080206283 Vaccine Against Sars |
| 08/28/2008 | US20080206282 Chimeric lyssavirus nucleic acids and polypeptides |
| 08/28/2008 | US20080206270 vaccines that rely on eliciting cellular immune responses, specifically induction of cytotoxic T lymphocytes (CTL), against cancer cells and virus-infected cells via administration of a vaccine comprising a fusion peptide or a modified peptide; derived from antigens PRAME, OFA/iLRP, STEAP and SURVIVIN |
| 08/28/2008 | US20080206269 stimulate the resuscitation of bacteria after true dormancy; cognate receptors, convertases, respective genes and inhibitors or mimetics |
| 08/28/2008 | US20080206268 HA-1 epitopes and uses thereof |
| 08/28/2008 | US20080206267 Inactivation Of Genes Of The Mep Pathway |
| 08/28/2008 | US20080206266 Carbohydrate ligand that specifically binds to a leczyme; nucleic acid sequence encoding a nonclassical MHC class I heavy chain; ability to associate with a beta 2 microglobulin; major histocompatibility complex transplantation molecules |
| 08/28/2008 | US20080206263 Methods and Compositions for Prognosing, Detecting, and Treating Age-Related Macular Degeneration |
| 08/28/2008 | US20080206261 administering RegIII protein or Ins2 protein; expression of the IBD marker was decreased |
| 08/28/2008 | US20080206260 Chimeric Tbp-toxin proteins as mucosal adjuvants for vaccination against neisseriae |
| 08/28/2008 | US20080206259 Unique and specific combinations of polyclonal anti-TNF and anti-IL-6 antibodies directed to cytokines; high-risk patients, including immunocompromised patients such as surgical and other hospitalized patients, low birth weight infants, and burn and trauma victims |
| 08/28/2008 | US20080206257 Reducing epithelial toxicity during cancer therapy by administering KGF with e.g. erlotinib, Iressa(TM), canertinib, or a monoclonal antibody against EGFR; side effect reduction of diarrhea, rash |
| 08/28/2008 | US20080206253 inhibitor of p38 beta MAP kinase; interfering RNA, short hairpin RNA, ribozyme, antisense oligonucleotide, or protein inhibitor; monoclonal antibody, a polyclonal antibody, a peptide, or a small molecule |
| 08/28/2008 | US20080206252 Novel Polypeptides, and Nucleic Acids Encoding the Same |
| 08/28/2008 | US20080206250 Compositions and methods for the therapy and diagnosis of breast cancer |
| 08/28/2008 | US20080206249 comprise one or more breast tumor polypeptides, immunogenic portions thereof, polynucleotides that encode such polypeptides, antigen presenting cell that expresses such polypeptides, and T cells that are specific for cells expressing such polypeptides |
| 08/28/2008 | US20080206247 Glycoprotein VI fusion proteins |
| 08/28/2008 | US20080206246 Polypeptides with enhanced anti-inflammatory and decreased cytotoxic properties and relating methods |
| 08/28/2008 | US20080206245 Compositions and methods for the therapy and diagnosis of breast cancer |
| 08/28/2008 | US20080206244 Compositions and methods for the therapy and diagnosis of breast cancer |
| 08/28/2008 | US20080206243 administering an effective amount of VEGFR agonist; e.g., VEGF, antibodies directed to Flt1, Flt1 ligands, Flt1 small molecule activators, or Flt1 selective agents in a pharmaceutically acceptable carrier |
| 08/28/2008 | US20080206238 Angiogenesis-Inhibiting Chimeric Protein and the Use |
| 08/28/2008 | US20080206234 Compositions and methods for the therapy and diagnosis of breast cancer |
| 08/28/2008 | US20080206232 Compositions and Methods For Modulating Pgc-1Beta to Treat Lipid-Related Diseases and Disorders |
| 08/28/2008 | US20080206231 Using herstatin as therapeutic in treatment and prevention of diabetes, cardiac disease, diabetes-associated vascular disease, atherosclerosis, hypertension, obesity, lipid metabolism obesity and neurodegenerative disorders |
| 08/28/2008 | US20080206230 Peptides Derived from Human Bplp Protein, Polynucleotides Coding for Said Peptides and Antibodies Directed Against Said Peptides |
| 08/28/2008 | US20080206228 Medicament for topical use containing hyaluronic acid and proteolytic enzyme collagenase for use as wound healing agent |
| 08/28/2008 | US20080206227 Factor vii conjugates for selectively treating neovascularization disorders |
| 08/28/2008 | US20080206226 Agent for promoting osteogenesis and/or inhibiting bone resorption |
| 08/28/2008 | US20080206225 Closed Container Comprising an Activated Factor VII Polypeptide, Processes for the Preparation of the Same, and a Kit and a Method for Use of the Kit |
| 08/28/2008 | US20080206224 Muscle contraction treatment utilizing botulinum toxin |
| 08/28/2008 | US20080206223 Treatment of pompe's disease |
| 08/28/2008 | US20080206222 Fullerenes; clathrates; side effect reduction |
| 08/28/2008 | US20080206221 Nicotinamide Riboside Kinase Compositions and Methods for Using the Same |
| 08/28/2008 | US20080206220 Using NADH:flavin oxidoreductase as screening tool in identifying modulators for use in treatment of fungal infection |
| 08/28/2008 | US20080206219 Using cytokine modulators as therapeutic tools in treatment of vascular permeability disorders |
| 08/28/2008 | US20080206218 T-helper cell peptide epitopes for use in targeting and treatment of cell prolferative disorders; immunotherapy |
| 08/28/2008 | US20080206217 Tumor-associated Peptides Binding Promiscuously to Human Leukocyte Antigen (HLA) Class II Molecules |
| 08/28/2008 | US20080206216 T-helper cell peptide epitopes for use in targeting and treatment of cell prolferative disorders; immunotherapy |
| 08/28/2008 | US20080206210 gene therapy by intrathymic administration; lentiviral vectors |
| 08/28/2008 | US20080206195 Compositions and Methods for Treating Disorders Associated with Abnormal Phosphate Metabolism |
| 08/28/2008 | US20080206194 Inducing estrogen receptor-alpha expression by administering peroxisome proliferator-activated receptor gamma (PPAR gamma) antagonist |
| 08/28/2008 | US20080206193 Angiogenesis inhibitors; immunomodulators; side effect reduction |
| 08/28/2008 | US20080206192 Treating cell proliferative disorders via administration of mixture comprising interleukin-21 and anti-cancer monoclonal antibody (Alemtuzumab) |
| 08/28/2008 | US20080206191 Compounds for the Treatment of Hepatitis C |
| 08/28/2008 | US20080206190 Glycosylated IL-7, Preparation And Uses |
| 08/28/2008 | US20080206189 Using water-soluble polymer conjugated interleukin-18 as therapeutic in treatment and prevention of cell proliferative disorders |
| 08/28/2008 | US20080206182 biocompatible hydroxyalkyl starch, dextran or polyethylene glycol polymers functionalized by an aminooxy group; improved circulatory life time in vivo; reduced antigenicity and immunogenicity of the proteins; therapeutic proteins such as EPO, G-CSF, Factor VII, Factor IX, IFN beta, AT III, A1AT, Factor V |
| 08/28/2008 | US20080206169 for skin lightening; preventing, retarding, and/or treating uneven skin tone; regulating the condition of mammalian keratinous tissue |
| 08/28/2008 | US20080206160 Antimicrobial protein cecropin B, and exhibit cell stimulatory, migratory and antiinflammatory properties; preventing and reversing skin surface damage; wound healing include abrasions, blisters, burns, lacerations, ulcers, bruises, rashes, scars, and the effects of aging |
| 08/28/2008 | US20080206146 Capable of crossing the blood brain barrier and having differential affinity for a tissue in the brain, such as diseased tissue; diagnosis; drug screening with animal model |
| 08/28/2008 | US20080206142 Use to treat dyslipidemic disorders, stroke and myocardial infarction; detecting plaque in vessels using the labeled peptides; peptides with apolipoprotein A-I (apoA-I) domains |
| 08/28/2008 | US20080206133 Patient-specific anticancer monoclonal antibodies for staging and diagnosis of a cancer, treating tumors and metastases; monoclonal antibody produced by hybridoma; conjugates with cytotoxic agents for tissue-targeted therapy |
| 08/28/2008 | US20080206132 Cancerous Disease Modifying Antibodies |
| 08/28/2008 | US20080202967 Treatment pad comprising hydrophilic polymer consisting of polyvinyl alcohol, polyoxyethylene glycol, polyacrylamide, polyacrylic acid, polyhydroxyethyl methacrylate, and/or polyoxyethylene glycol; preservatives and water; self-supporting; for eyes or surrounding tissue; containers conjoined by hinges |
| 08/28/2008 | DE102007010306A1 Bispezifisches Fusionsprotein mit therapeutischem und diagnostischem Potenzial The bispecific fusion protein with therapeutic and diagnostic potential |
| 08/28/2008 | CA2716421A1 Agent for use in the case of fructose intolerance |
| 08/28/2008 | CA2680063A1 Compositions and methods for treating glycogen storage diseases |
| 08/28/2008 | CA2678986A1 Erythropoietin fusion protein |
| 08/28/2008 | CA2678967A1 Rna targeting compounds and methods for making and using same |
| 08/28/2008 | CA2678875A1 Prevention and treatment for osteonecrosis and osteoradionecrosis of the jaw |
| 08/28/2008 | CA2678806A1 Treating adhd and other diseases involving inflammation |
| 08/28/2008 | CA2678755A1 Peptide vaccines for cancers expressing tumor-associated antigens |
| 08/28/2008 | CA2678618A1 Modulation of nkt cell activity with antigen-loaded cd1d molecules |
| 08/28/2008 | CA2678493A1 Methods to activate or block the hla-e/qa-1 restricted cd8+ t cell regulatory pathway to treat immunological disease |
| 08/28/2008 | CA2678409A1 Inoculation of recombinant viral vectors for rapid pre-exposure prevention and post-exposure protection against alphavirus-induced encephalitides |
| 08/28/2008 | CA2678088A1 Combination therapy using tnf and alfa-galactosyl ceramide |
| 08/28/2008 | CA2677023A1 Method of purification of hydrophobic proteins |
| 08/28/2008 | CA2675622A1 Hgf preparation |
| 08/27/2008 | EP1961821A1 Erythropoietin fusion protein |
| 08/27/2008 | EP1961820A2 Lage-1 tumor associated nucleic acids |
| 08/27/2008 | EP1961819A2 Composition and methods for the therapy and diagnosis of lung cancer |
| 08/27/2008 | EP1961818A2 Novel fetal genes |
| 08/27/2008 | EP1961816A1 Novel highly functional enzyme having modified substrate-specificity |
| 08/27/2008 | EP1961813A2 Human cyclin-dependent kinase (hPNQALRE) |
| 08/27/2008 | EP1961811A1 Novel cytokine ZCYTOR17 ligand |
| 08/27/2008 | EP1961765A1 Truncated PTH peptides with a cyclic conformation |
| 08/27/2008 | EP1961764A1 Sugar chain adduct of peptide and pharmaceutical comprising the same as active ingredient |